‘Extreme’ monitoring fails to boost survival in breast cancer patients

Extreme users of disease-monitoring tests do not have significantly improved overall survival, investigators reported. A review of Surveillance, Epidemiology, and End Results (SEER) Medicare data...
Source: Ob.Gyn. News - Category: OBGYN Source Type: research